Page 173
APPENDIX B
Public Session Agendas
Committee on the Elimination of Tuberculosis in the United States
FIRST COMMITTEE MEETING
March 8–9, 1999
Please refer to the page image for an unflawed representation of this content.
|
Page 174
Onorato is the Chief of the Surveillance, Epidemiology and Investigations Branch, in the Tuberculosis Division and will be presenting on the U.S. Tuberculosis epidemiology and foreign-born Tuberculosis in the United States. In previous discussions I have asked them to avoid encyclopedic “data dumps” and to try to highlight what they see as the key issues for the committee.
10:45 a.m.
Break
11:00 a.m.
TB Research
Ann Ginsberg, National Institutes of Health
Dr. Ginsberg is the program officer for Tuberculosis projects at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. I have asked her to provide an overview of Tuberculosis research in general, not just what is happening in the National Institutes of Health. I also asked her to avoid an encyclopedic list but to provide a sense of the research priorities, whether work is under way in that area, and where there are research gaps.
11:30 a.m.
U.S. Role in Global Tuberculosis
Amy Bloom, U.S. Agency for International Development
Dr. Bloom is a Centers for Disease Control and Prevention assignee at the U.S. Agency for International Development providing technical support in the Health and Nutrition Division. AID has just recently allocated funds for Tuberculosis program support and has provided limited support to the World Health Organization and I asked her to outline this for the committee.
Page 175
Bess Miller, Centers for Disease Control and Prevention
Dr. Miller is Assistant Director for Science in the Tuberculosis Division at Centers for Disease Control and Prevention. She will be presenting briefly in this section on an effort by the World Health Organization to develop a global action plan for tuberculosis. Centers for Disease Control and Prevention is involved in and supports this effort.
12:00 p.m.
Information Needs and Sources
Commissioned Studies
Invited Expert Presentations
Site Visits
12:45 p.m.
Adjourn Public Session
1:00 p.m. (closed meeting)
Committee Planning
Future Meetings
3:00 p.m.
Adjourn
FIRST WORKSHOP
June 7–8, 1999
Please refer to the page image for an unflawed representation of this content.
|
Page 176
10:45 a.m.
Population Specific Issues
-
Tuberculosis Elimination at the United States-Mexico Border
Miguel Escobedo, Texas Department of Public Health
-
Tuberculosis Elimination in Migrant and Seasonal Workers
Deliana Garcia, Migrant Clinicians Network
-
Tuberculosis Elimination in the Homeless/ Marginally Housed
Andrew Moss, University of California at San Francisco
12:15 p.m.
Lunch
1:00 p.m.
Case Studies
-
Tuberculosis Elimination, the New York Experience
Paula Fujiwara, New York City Department of Health
-
Impact of Directly Observed Therapy
Stephen Weis, University of North Texas Health Science Center at Fort Worth
-
Tuberculosis in the District of Columbia
Michael Richardson, Medical Society of DC
-
TB Elimination in Low-Incidence Areas
Carol Poszik, South Carolina Department of Health and Environmental Control
3:00 p.m.
Break
3:20 p.m.
Contact Investigations and Outbreaks
-
Expanded Contact Investigations
Nancy Dunlap, University of Alabama at Birmingham.
-
Managing Tuberculosis Outbreaks
Ida Onorato, Centers for Disease Control and Prevention
4:40 p.m.
Employee Health and Institutional Transmission
-
Revised OSHA Regulations
Amanda Edens, Occupational Safety and Health Administration
Page 177
-
Staff Track
Eugene McCray, Centers for Disease Control and Prevention
6:00 p.m.
Adjourn
Tuesday, June 8
8:00 a.m.
Tuberculosis in the Foreign Born
-
Legal Issues in Immigration
Sophia Cox, Immigration and Naturalization Service
-
Tuberculosis Screening of Immigrants
Nancy Binkin, Centers for Disease Control and Prevention
-
Tuberculosis Elimination (Screening and Prevention) Among Immigrants in the United States
Charles Nolan, Seattle-King County Department of Public Health
9:30 a.m.
General Discussion and Questions
10:00 a.m.
Break
10:15 a.m.
Economic Issues
-
Costs of Tuberculosis
Zachary Taylor, Centers for Disease Control and Prevention
-
Securing Funding for Tuberculosis Elimination
Tim Westmoreland, Georgetown University Law Center
11:35 a.m.
Modeling Tuberculosis Elimination
Sally Blower, University of California at San Francisco
12:00 p.m.
Adjourn
Page 178
THIRD MEETING
August 17–19, 1999
Please refer to the page image for an unflawed representation of this content.
|
Page 179
3:15–4:00 p.m.
Innovative Programs in Health Communication
Scott Ratzan, Academy for Educational Development
4:00–4:45 p.m.
Risk Communication
Julie Downs, Carnegie Mellon University
4:45–5:30 p.m.
General Discussion
Wednesday, August 18
8:30 a.m.–5:30 p.m.
Closed Session
Thursday, August 19
8:30 a.m.–1:00 p.m.
Closed Session
FIFTH MEETING
January 11–13, 2000
Please refer to the page image for an unflawed representation of this content.
|
Page 180
Andrew I. Schoenholtz, Director of Law and Policy Studies, Georgetown University
Douglas Shenson, M.D. M.P.H., Director, Human Rights Clinic, Montefiore Medical Center, North Central Bronx Hospital
8:45 a.m.–10:15 a.m.
Can tuberculin skin testing be conducted for immigrants to the United States in their country of origin?
Can a B3 category be created for individuals with a positive tuberculin skin test and people in this category be processed much as category B1 and B2 immigrants are processed now?
Can the health screening requirements differ on the basis of country of origin?
Is the estimated prevalence of infection in other countries a suitable criterion for deciding who should be tuberculin tested prior to arrival?
Should immigrants from Mexico be tuberculin skin tested prior to immigration, since individuals born in Mexico account for the greatest number of foreign-born cases, even though the official estimates of the prevalence of infection is not above the global median?
10:15 a.m.–10:30 a.m.
Break
10:30 a.m.–12:30 p.m.
Can the completion of tuberculosis screening for immigrants with Class B waivers be tied to the right to permanent residence in the United States?
Should the completion of tuberculosis screening for immigrants with Class B waivers be tied to the right to permanent residence in the United States?
Should the completion of treatment for latent infection be legally mandated for individuals with the highest risk for developing tuberculosis?
Page 181
Can/should individuals, other than immigrants and refugees, entering the United States for long periods of time, such as students, trainees, workers, and their families, be required to have screening for tuberculosis?
Could the completion of tuberculosis screening be made the responsibility of the sponsor of the students, trainees, workers, and their families?
12:30 p.m.
Adjourn the Public Session
12:30–1:30 p.m.
Lunch
1:30–5:30 p.m.
Executive Session (Closed to the Public)
Wednesday, January 12
8:30 a.m.–5:30 p.m.
Executive Session (Closed to the Public)
Continue Review of Report Draft
Thursday, January 13
8:30 a.m.–3:30 p.m.
Executive Session (Closed to the Public)
Continue Review of Report Draft
Discuss Report Release and Dissemination Plan